MoneyWorks4Me

Caplin Point Laboratories recommends final dividend

22 Nov 2011 Evaluate

Caplin Point Laboratories has informed that the board of directors of the company at its meeting held on November 21, 2011, inter alia, has recommended a final dividend of Re 1.50 per share (15%) on the equity capital for the year ended June 30, 2011.

The above information is part of the company’s filing submitted to the BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..